4 Results

People

  1. Azzoli
    Azzoli
  2. Kris
    Kris
  3. Krug
    Krug
  4. Price
    Price
  5. Riely
    Riely
  6. Rizvi
    Rizvi
  7. Bains
    Bains
  8. Chaft
    Chaft
  9. Downey
    Downey
  10. Finley
    Finley

Groups

  1. Department of Medicine (4)
  2. Solid Tumor Oncology Division (4)
  3. Thoracic Oncology (4)
  4. Body Imaging Service (2)
  5. Radiology, Department of (2)
  6. Surgery (2)
  7. Survivorship Research (2)
  1. "aged"
  2. "Katharine Price"
  3. "Mark Kris"
Formats
  1. Journal Article (4)
Groups
  1. Department of Medicine (4)
  2. Solid Tumor Oncology Division (4)
  3. Thoracic Oncology (4)
  4. Body Imaging Service (2)
  5. Radiology, Department of (2)
  6. Surgery (2)

More Groups

People
  1. Christopher Azzoli (4)
  2. Gregory Riely (4)
  3. Katharine Price (4)
  4. Lee Krug (4)
  5. Mark Kris (4)
  6. Naiyer Rizvi (4)

More People

Years
  1. 2013 (2)
  2. 2012 (1)
  3. 2010 (1)
Publications
  1. Journal of Thoracic Oncology (3)
  2. Cancer Chemotherapy and Pharmacology (1)
Publishers
  1. Elsevier Inc. (3)
  2. Springer (1)

Results (4)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Risk of hemoptysis in patients with resected squamous cell and other high-risk lung cancers treated with adjuvant bevacizumab
    Journal Article

    Hellmann, M. D.; Chaft, J. E.; Rusch, V.; Ginsberg, M. S.; Finley, D. J.; Kris, M. G.; Price, K. A. R.; Azzoli, C. G.; Fury, M. G.; Riely, G. J.; more...
    Cancer Chemotherapy and Pharmacology (2013)

    Fulltext@MSK | Save
  • Phase II trial of neoadjuvant bevacizumab plus chemotherapy and adjuvant bevacizumab in patients with resectable nonsquamous non-small-cell lung cancers
    Journal Article

    Chaft, J. E.; Rusch, V.; Ginsberg, M. S.; Paik, P. K.; Finley, D. J.; Kris, M. G.; Price, K. A. R.; Azzoli, C. G.; Fury, M. G.; Riely, G. J.; more...
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Phase II study of the multitargeted tyrosine kinase inhibitor XL647 in patients with non-small-cell lung cancer
    Journal Article

    Pietanza, M. C.; Gadgeel, S. M.; Dowlati, A.; Lynch, T. J.; Salgia, R.; Rowland, K. M. Jr; Wertheim, M. S.; Price, K. A.; Riely, G. J.; Azzoli, C. G.; more...
    Journal of Thoracic Oncology (2012)

    Fulltext@MSK | Save
  • Phase II trial of gefitinib and everolimus in advanced non-small cell lung cancer
    Journal Article

    Price, K. A.; Azzoli, C. G.; Krug, L. M.; Pietanza, M. C.; Rizvi, N. A.; Pao, W.; Kris, M. G.; Riely, G. J.; Heelan, R. T.; Arcila, M. E.; more...
    Journal of Thoracic Oncology (2010)

    Fulltext@MSK | Save